News
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback